176 related articles for article (PubMed ID: 28594007)
21. Gold(III) compounds-mediated inhibition of lung cancer cell proliferation.
Bostancioğlu RB; Kaya M; Koparal AT; Benkli K
Anticancer Drugs; 2016 Mar; 27(3):225-34. PubMed ID: 26825752
[TBL] [Abstract][Full Text] [Related]
22. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
[TBL] [Abstract][Full Text] [Related]
23. Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.
Raza MK; Gautam S; Garai A; Mitra K; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Sep; 56(18):11019-11029. PubMed ID: 28846407
[TBL] [Abstract][Full Text] [Related]
24. A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione.
Purkait K; Karmakar S; Bhattacharyya S; Chatterjee S; Dey SK; Mukherjee A
Dalton Trans; 2015 Apr; 44(13):5969-73. PubMed ID: 25742181
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Activity of Iridium(III) Complexes Based on a Pyrazole-Appended Quinoline-Based BODIPY.
Paitandi RP; Mukhopadhyay S; Singh RS; Sharma V; Mobin SM; Pandey DS
Inorg Chem; 2017 Oct; 56(20):12232-12247. PubMed ID: 28956596
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
[TBL] [Abstract][Full Text] [Related]
27. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
28. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
[TBL] [Abstract][Full Text] [Related]
30. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potential.
Muenzner JK; Biersack B; Kalie H; Andronache IC; Kaps L; Schuppan D; Sasse F; Schobert R
ChemMedChem; 2014 Jun; 9(6):1195-204. PubMed ID: 24648184
[TBL] [Abstract][Full Text] [Related]
31. Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes.
Biswal D; Pramanik NR; Chakrabarti S; Drew MGB; Acharya K; Chandra S
Dalton Trans; 2017 Dec; 46(47):16682-16702. PubMed ID: 29168865
[TBL] [Abstract][Full Text] [Related]
32. Multi-Target Metal-Based Anticancer Agents.
Chen ZF; Orvig C; Liang H
Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
[TBL] [Abstract][Full Text] [Related]
33. Rapid Synthesis and Antiproliferative Properties of Polyazamacrocycle-Based Bi- and Tetra-Gold(I) Phosphine Dithiocarbamate Complexes.
Florès O; Velic D; Mabrouk N; Bettaïeb A; Tomasoni C; Robert JM; Paul C; Goze C; Roussakis C; Bodio E
Chembiochem; 2019 Sep; 20(17):2255-2261. PubMed ID: 30969460
[TBL] [Abstract][Full Text] [Related]
34. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
35. New heteronuclear gold(I)-platinum(II) complexes with cytotoxic properties: are two metals better than one?
Wenzel M; Bigaeva E; Richard P; Le Gendre P; Picquet M; Casini A; Bodio E
J Inorg Biochem; 2014 Dec; 141():10-16. PubMed ID: 25172993
[TBL] [Abstract][Full Text] [Related]
36. Modulating anti-inflammatory and anticancer properties by designing a family of metal-complexes based on 5-nitropicolinic acid.
García-García A; Medina-O'donnell M; Rojas S; Cano-Morenilla M; Morales J; Quesada-Moreno MM; Sainz J; Vitorica-Yrezabal IJ; Rodríguez-Diéguez A; Navarro A; Reyes-Zurita FJ
Dalton Trans; 2024 May; 53(21):8988-9000. PubMed ID: 38721696
[TBL] [Abstract][Full Text] [Related]
37. The Syntheses, Structures, Fluorescence Properties and Biological Activity of two Novel Zinc(II) Complexes Controlled by the Tripodal Imidazole Ligand.
Gao EJ; Zhang S; Meng Y; Zhao FC; Ma XY; Jin HT; Liu SJ; Ge J; Sun YG; Zhang WZ; Zhu MC
J Fluoresc; 2016 Jul; 26(4):1331-9. PubMed ID: 27210797
[TBL] [Abstract][Full Text] [Related]
38. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms underlying the cytotoxic activity of syn/anti-isomers of dinuclear Au(I) NHC complexes.
Dominelli B; Jakob CHG; Oberkofler J; Fischer PJ; Esslinger EM; Reich RM; Marques F; Pinheiro T; Correia JDG; Kühn FE
Eur J Med Chem; 2020 Oct; 203():112576. PubMed ID: 32693297
[TBL] [Abstract][Full Text] [Related]
40. New Luminescent Polynuclear Metal Complexes with Anticancer Properties: Toward Structure-Activity Relationships.
Wenzel M; de Almeida A; Bigaeva E; Kavanagh P; Picquet M; Le Gendre P; Bodio E; Casini A
Inorg Chem; 2016 Mar; 55(5):2544-57. PubMed ID: 26867101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
